NeueHealth, Inc. (NYSE:NEUE) Short Interest Update

NeueHealth, Inc. (NYSE:NEUE) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 9,200 shares, a decline of 25.8% from the February 13th total of 12,400 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average trading volume of 38,400 shares, the short-interest ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

Insider Transactions at NeueHealth

In other NeueHealth news, CEO George Lawrence Mikan III sold 12,440 shares of the company’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the sale, the chief executive officer now directly owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. This represents a 4.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jay Matushak sold 4,970 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the sale, the chief financial officer now directly owns 17,747 shares of the company’s stock, valued at $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 126,836 shares of company stock valued at $844,797 over the last three months. Corporate insiders own 64.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Partners Group Holding AG bought a new position in shares of NeueHealth during the 3rd quarter valued at approximately $463,000. Northern Trust Corp grew its position in shares of NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after acquiring an additional 13,074 shares during the period. Finally, Virtu Financial LLC bought a new position in shares of NeueHealth during the 4th quarter valued at approximately $76,000. 63.88% of the stock is owned by institutional investors.

NeueHealth Price Performance

Shares of NeueHealth stock traded down $0.38 on Monday, reaching $4.71. 81,052 shares of the company traded hands, compared to its average volume of 18,693. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66. The company has a 50 day moving average of $7.21 and a 200 day moving average of $6.01. The firm has a market capitalization of $38.98 million, a PE ratio of -0.09 and a beta of 0.56.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.